Pacific Biosciences Of California (PACB) Total Debt Growth (1y) (2011 - 2022)
Pacific Biosciences Of California (PACB) Total Debt Growth (1y) (2011 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 5.50% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.12% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 19.06% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 15.70% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -5.48% |
| 10 | Pacific Biosciences Of California | 426.62 Mn | 150.66 Mn | 12.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 4,316.43% |
| Dec 31, 2019 | 7.78% |
| Dec 31, 2018 | 7.51% |
| Sep 30, 2018 | 37.57% |
| Jun 30, 2018 | 35.25% |
| Mar 31, 2018 | 4.29% |
| Dec 31, 2017 | -15.34% |
| Sep 30, 2017 | -33.80% |
| Jun 30, 2017 | -32.62% |
| Mar 31, 2017 | -12.58% |
| Dec 31, 2016 | 7.75% |
| Sep 30, 2016 | 6.66% |
| Jun 30, 2016 | 6.38% |
| Mar 31, 2016 | 6.12% |
| Dec 31, 2015 | 6.84% |
| Sep 30, 2015 | 6.43% |
| Jun 30, 2015 | 6.22% |
| Mar 31, 2015 | 6.02% |
| Dec 31, 2014 | 4.83% |
| Sep 30, 2014 | 5.63% |